Literature DB >> 17849487

Dystonin/Bpag1--a link to what?

Kevin G Young1, Rashmi Kothary.   

Abstract

The dystonin/Bpag1 cytoskeletal interacting proteins play important roles in maintaining cytoarchitecture integrity in skin and in the neuromuscular system. The most profound phenotype observed in the dystonin mutant dystonia musculorum (dt) mice is a severe movement disorder, attributed in large part to sensory neuron degeneration. The molecular basis for this phenotype is currently not clear, despite several studies indicating possible causes for the pathology in dt mice. Complicating the picture of what essential dystonin functions are lost in dt mice is the fact that our understanding of the very nature of what dystonin is has evolved greatly over the past decade. Elucidating the roles of dystonin most relevant to neuronal function and survival should help to shed light on some of the common mechanisms underlying neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17849487     DOI: 10.1002/cm.20235

Source DB:  PubMed          Journal:  Cell Motil Cytoskeleton        ISSN: 0886-1544


  22 in total

1.  BPAG1-e restricts keratinocyte migration through control of adhesion stability.

Authors:  Magdalene Michael; Rumena Begum; Kenneth Fong; Celine Pourreyrone; Andrew P South; John A McGrath; Maddy Parsons
Journal:  J Invest Dermatol       Date:  2013-09-11       Impact factor: 8.551

Review 2.  Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration.

Authors:  Rodolphe Perrot; Raphael Berges; Arnaud Bocquet; Joel Eyer
Journal:  Mol Neurobiol       Date:  2008-07-23       Impact factor: 5.590

3.  The structure of the ankyrin-binding site of beta-spectrin reveals how tandem spectrin-repeats generate unique ligand-binding properties.

Authors:  Paul R Stabach; Ivana Simonović; Miranda A Ranieri; Michael S Aboodi; Thomas A Steitz; Miljan Simonović; Jon S Morrow
Journal:  Blood       Date:  2009-01-23       Impact factor: 22.113

4.  Reduced Proliferation of Oligodendrocyte Progenitor Cells in the Postnatal Brain of Dystonia Musculorum Mice.

Authors:  M Ibrahim Hossain; Masao Horie; Hirohide Takebayashi
Journal:  Neurochem Res       Date:  2017-06-29       Impact factor: 3.996

5.  Transgenic expression of neuronal dystonin isoform 2 partially rescues the disease phenotype of the dystonia musculorum mouse model of hereditary sensory autonomic neuropathy VI.

Authors:  Andrew Ferrier; Tadasu Sato; Yves De Repentigny; Sabrina Gibeault; Kunal Bhanot; Ryan W O'Meara; Anisha Lynch-Godrei; Samantha F Kornfeld; Kevin G Young; Rashmi Kothary
Journal:  Hum Mol Genet       Date:  2013-12-30       Impact factor: 6.150

6.  Serum anti-BPAG1 auto-antibody is a novel marker for human melanoma.

Authors:  Takashi Shimbo; Atsushi Tanemura; Takehiko Yamazaki; Katsuto Tamai; Ichiro Katayama; Yasufumi Kaneda
Journal:  PLoS One       Date:  2010-05-10       Impact factor: 3.240

7.  Hearts of dystonia musculorum mice display normal morphological and histological features but show signs of cardiac stress.

Authors:  Justin G Boyer; Kunal Bhanot; Rashmi Kothary; Céline Boudreau-Larivière
Journal:  PLoS One       Date:  2010-03-01       Impact factor: 3.240

8.  Mouse ACF7 and drosophila short stop modulate filopodia formation and microtubule organisation during neuronal growth.

Authors:  Natalia Sanchez-Soriano; Mark Travis; Federico Dajas-Bailador; Catarina Gonçalves-Pimentel; Alan J Whitmarsh; Andreas Prokop
Journal:  J Cell Sci       Date:  2009-07-15       Impact factor: 5.285

Review 9.  Mouse forward genetics in the study of the peripheral nervous system and human peripheral neuropathy.

Authors:  Darlene S Douglas; Brian Popko
Journal:  Neurochem Res       Date:  2008-05-15       Impact factor: 3.996

10.  Novel mutations in dystonin provide clues to the pathomechanisms of HSAN-VI.

Authors:  Fiore Manganelli; Silvia Parisi; Maria Nolano; Feifei Tao; Simona Paladino; Chiara Pisciotta; Stefano Tozza; Claudia Nesti; Adriana P Rebelo; Vincenzo Provitera; Filippo M Santorelli; Michael E Shy; Tommaso Russo; Stephan Zuchner; Lucio Santoro
Journal:  Neurology       Date:  2017-05-03       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.